Cognitive impairment and substance abuse history as predictors of the temporal stability of negative symptoms in schizophrenia

被引:14
|
作者
Lysaker, PH
Bell, MD
Bioty, SM
Zito, WS
机构
[1] INDIANA UNIV PURDUE UNIV,INDIANAPOLIS,IN 46202
[2] W HAVEN VET AFFAIRS MED CTR,NEW HAVEN,CT
[3] YALE UNIV,SCH MED,NEW HAVEN,CT
关键词
NONDEFICIT FORMS; SYNDROME SCALE; COCAINE ABUSE; DEFICIT; RELIABILITY;
D O I
10.1097/00005053-199701000-00004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Research has not consistently indicated that negative symptoms in schizophrenia are temporally stable. One possible explanation for this is that stable negative symptoms are a characteristic of only some individuals with schizophrenia. The current study explored whether cognitive impairment and stimulant abuse history were associated with an-count of change in negative symptom level over a 1-year period. Results indicated that among 72 subjects with schizophrenia, performance on the Wisconsin Card Sorting Test and history of stimulant abuse significantly accounted for 18% of the variance in symptom variability after age, intelligence quotient, and initial symptom severity were controlled. As hypothesized, poorer performance on the Wisconsin Carding Sorting Test was associated with less symptom variability, whereas a more extensive stimulant abuse history was associated with greater variability. A discriminant function analysis was able to correctly classify 96% of subjects as having stable symptoms but only 30% as having unstable symptoms indicating a sensitive, but not specific, classification. This finding suggests that cognitive deficits may be a necessary but insufficient condition for temporal stability of negative symptoms and that negative symptoms in schizophrenia are a complex phenomenon best understood in the context of other features of illness and psychosocial variables.
引用
收藏
页码:21 / 26
页数:6
相关论文
共 50 条
  • [21] Negative symptoms and cognitive impairment are associated with distinct motivational deficits in treatment resistant schizophrenia
    Y. Saleh
    I. Jarratt-Barnham
    P. Petitet
    E. Fernandez-Egea
    S. G. Manohar
    M. Husain
    Molecular Psychiatry, 2023, 28 : 4831 - 4841
  • [22] The effects of cognitive impairment and substance abuse on psychiatric hospitalizations
    Jackson, CT
    Fein, D
    Essock, SM
    Mueser, KT
    COMMUNITY MENTAL HEALTH JOURNAL, 2001, 37 (04) : 303 - 312
  • [23] Stability of positive and negative symptoms in schizophrenia
    Ribeyre, JM
    Dollfus, S
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 1996, 22 : 29 - 31
  • [24] STABILITY OF POSITIVE AND NEGATIVE SYMPTOMS IN SCHIZOPHRENIA
    MALLA, AK
    NORMAN, RMG
    WILLIAMSON, P
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 1993, 38 (09): : 617 - 621
  • [25] Cognitive impairment in substance-abusing patients with schizophrenia
    Hagger, C
    Friedman, L
    Kenny, J
    Hyde, J
    Buckley, P
    SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 133 - 133
  • [26] Movement disorders in patients with schizophrenia and a history of substance abuse
    Hansen, Lars K.
    Nausheen, Bina
    Hart, Deborah
    Kingdon, David
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2013, 28 (02) : 192 - 197
  • [27] Atypical medications in schizophrenia patients with a history of substance abuse
    Scheller-Gilkey, G
    Woolwine, B
    Robinson, I
    Gay, O
    Miller, AH
    SCHIZOPHRENIA RESEARCH, 2000, 41 (01) : 213 - 214
  • [28] RELATIONSHIP OF POSITIVE AND NEGATIVE SYMPTOMS TO COCAINE ABUSE IN SCHIZOPHRENIA
    LYSAKER, P
    BELL, M
    BEAMGOULET, J
    MILSTEIN, R
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 1994, 182 (02) : 109 - 112
  • [29] TRIHEXYPHENIDYL ABUSE - THERAPEUTIC IMPLICATIONS FOR NEGATIVE SYMPTOMS OF SCHIZOPHRENIA
    FISCH, RZ
    ACTA PSYCHIATRICA SCANDINAVICA, 1987, 75 (01) : 91 - 94
  • [30] SUBSTANCE-ABUSE AND SCHIZOPHRENIA - EFFECT ON SYMPTOMS BUT NOT ON NEUROCOGNITIVE FUNCTION
    CLEGHORN, JM
    KAPLAN, RD
    SZECHTMAN, B
    SZECHTMAN, H
    BROWN, GM
    FRANCO, S
    JOURNAL OF CLINICAL PSYCHIATRY, 1991, 52 (01) : 26 - 30